← Back to Clinical Trials
Recruiting NCT07289789

NCT07289789 Comparative Effects of Buteyko Versus Pilates Breathing Combined With McKenzie Neck Exercises on Lung Function and Chest Expansion in Asthmatic Patients With Forward Head Posture

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07289789
Status Recruiting
Phase —
Sponsor Foundation University Islamabad
Condition Asthma
Study Type INTERVENTIONAL
Enrollment 22 participants
Start Date 2025-08-20
Primary Completion 2026-01-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Pilates Breathing Combined with McKenzie Neck ExercisesMcKenzie Neck Exercises with Buteyko Breathing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 22 participants in total. It began in 2025-08-20 with a primary completion date of 2026-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Asthma is characterized by airway inflammation and hyperinflation that flattens the diaphragm and increases reliance on accessory neck muscles. Chronic overuse shortens these muscles and promotes forward head posture (FHP), which in turn compromises rib-cage motion and respiratory mechanics. Correcting FHP alongside breathing retraining may therefore improve lung function and symptoms in asthma. This interventional, parallel-group study investigates the combined effects of McKenzie neck exercises with two different breathing approaches on lung function, chest expansion, posture, and quality of life in adults with asthma. Participants are allocated to two groups for a 4-week program: Group A performs McKenzie neck exercises plus Pilates-based breathing; Group B performs McKenzie neck exercises plus Buteyko breathing.

Eligibility Criteria

Inclusion Criteria: * Age group 18-40years * Both males and females * Individuals clinically diagnosed with asthma that is well controlled (Level 1 and Level 2) with FHP * Not participated in any structured exercise regime for improving lung function during the past 6 months. * Individuals well tolerated with a current exercise plan of combination exercises. (Buteyko breathing/Pilate breathing and McKenzie neck exercises Exclusion Criteria: * -Level 3 and 4 asthma or status asthmatics. * Any congenital deformity of the chest wall * Any active infections like fever, TB * Those with any contraindication to exercise testing or training. * Recent history of any chest wall trauma * Any abdominal or cardio thoracic surgery * Any psychiatric illness * Unstable Cardiopulmonary disease i.e. unstable angina, heart failure, recent MI. * Unstable hemodynamic parameters (arterial pressure \>140mmhg systolic and \>90mmhg for diastolic * Pregnancy * Previous or parallel participation in interventional programs.

Contact & Investigator

Central Contact

Arzoo Bashir Awan, DPT

✉ arzoobashir66@gmail.com

📞 03215770272

Frequently Asked Questions

Who can join the NCT07289789 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07289789 currently recruiting?

Yes, NCT07289789 is actively recruiting participants. Contact the research team at arzoobashir66@gmail.com for enrollment information.

Where is the NCT07289789 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07289789 clinical trial?

NCT07289789 is sponsored by Foundation University Islamabad. The trial plans to enroll 22 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology